Understand 21 CFR Part 11 requirements for electronic records and signatures
Digital quality systems are now standard in pharmaceutical, biotech, and medical device organisations. However, moving to an electronic Quality Management System is not just a digital upgrade. It introduces regulatory responsibilities.
21 CFR Part 11 defines how electronic records and electronic signatures must be managed in FDA regulated environments. If your organisation uses an eQMS to manage quality procedures, deviations, CAPA, training, or audits, this regulation applies.
Understanding how Part 11 interacts with your eQMS is essential for inspection of readiness and data integrity. Below is a practical FAQ style guide for Quality Managers, Regulatory Affairs professionals and Compliance Leads.
21 CFR Part 11 is an FDA regulation that establishes criteria under which electronic records and electronic signatures are considered trustworthy, reliable and equivalent to paper records with handwritten signatures.
It applies when electronic systems manage records required by FDA regulations. If your organisation maintains quality documentation digitally, Part 11 compliance must be considered.
Part 11 applies when your electronic Quality Management System manages records that are required under FDA predicate rules.
This typically includes:
Quality procedures and SOPs
Deviation and CAPA records
Change control documentation
Training records
Audit documentation
Approval workflows with electronic signatures
If these records are stored electronically and used to demonstrate compliance, Part 11 requirements apply.
To align with Part 11, an eQMS must support:
System validation
The system must be tested and documented to prove it performs reliably and consistently.
Unique user identification
Each individual must have a unique login and cannot share credentials.
Role-based access control
Permissions must limit actions based on defined responsibilities.
Secure audit trails
All record creation, modification and approval activities must be automatically logged with user identity and timestamp.
Electronic signature controls
Electronic signatures must be uniquely linked to a specific individual and record, capturing the name, date, time and meaning of the signature.
Data integrity protection
Records must be protected against loss, alteration or unauthorised access.
System validation means demonstrating through documented evidence that the eQMS consistently performs according to its intended use.
Validation activities often include:
Installation qualification
Operational testing
Performance testing
Change control documentation
Validation is not a one-time activity. It must be maintained as the system evolves.
Electronic signatures must:
Be unique to one individual
Be linked to the record being signed
Include the signer’s name
Capture date and time of signing
Indicate the meaning of the signature, such as approval or review
Electronic signatures must not be reusable by other users or transferable
Who performed an action
What action was performed
When the action occurred
These logs must be secure and cannot be altered. They provide traceable evidence during FDA inspections and internal audits. Without reliable audit trails, electronic systems cannot meet Part 11 expectations.
Common challenges include:
Shared user accounts
Lack of formal system validation documentation
Inconsistent electronic signature controls
Manual override capabilities without trace
Incomplete documentation of procedures governing system use
These gaps often surface during regulatory inspections.
Learn how digital QMS software connects processes, reduces manual work and strengthens compliance.
A compliant eQMS embeds controls directly into workflows.
Document control is versioned and approved through structured routing.
Deviation and CAPA records are traceable with audit history.
Training records are linked to users and procedures.
Electronic signatures are uniquely tied to individuals.
Audit trails are automatically captured without manual intervention.
This structure reduces dependence on manual documentation and strengthens inspection of readiness.
Bizzmine provides a governed electronic Quality Management System designed for regulated environments.
It supports:
Controlled document management with version history
Secure electronic signatures
Automated audit trails
Role based access control
Structured deviation and CAPA workflows
Training management linked to procedures
Validation documentation support
By embedding traceability and governance into daily execution, Bizzmine helps regulated organisations maintain continuous compliance rather than reactive preparation.
Identify all electronic systems managing FDA-regulated records.
Assess whether validation of documentation is complete and current.
Ensure unique user identities and controlled permissions are enforced.
Verify that audit trails are enabled and immutable.
Review electronic signature controls for compliance with Part 11.
Train users on responsibilities related to electronic record management.
Schedule periodic internal reviews of compliance controls.
21 CFR Part 11 is not simply a technical requirement. It defines how digital quality must be governed. When electronic records are validated, traceable and securely signed:
Data integrity is strengthened
Inspection preparation time is reduced
Regulatory risk decreases
Quality execution becomes predictable
A compliant eQMS turns regulatory obligation into structured operational discipline.
21 CFR Part 11 is an FDA regulation that defines how electronic records and electronic signatures must be managed so they are considered trustworthy, reliable and equivalent to paper records with handwritten signatures. It applies to systems that store or manage regulated data.
Part 11 applies when an eQMS manages records required by FDA regulations. This includes quality procedures, CAPA records, deviations, training records, change control documentation and audit approvals that use electronic signatures.
Core requirements include system validation, unique user identification, role based access control, secure audit trails, controlled electronic signatures and data integrity protections that prevent unauthorised changes to regulated records.
Audit trails automatically record who performed an action, what was changed and when the action occurred. These records create traceable evidence during FDA inspections and ensure the integrity of electronic data.
System validation demonstrates through documented testing that the electronic system performs consistently according to its intended use. This includes installation qualification, operational testing and documented change control for updates.
A compliant eQMS enforces controlled workflows, captures audit trails automatically, links electronic signatures to individual users and protects regulated records from unauthorised modification. This structure strengthens data integrity and improves inspection readiness.
Join hundreds of organizations taking their compliance and safety to the next level with Bizzmine.
